Bettina Schuppelius
Beeke Peters1,3
Olga Pivovarova-Ramich- 1Research Group Molecular Nutritional Medicine, Department of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany
- 2Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany
- 3Institute of Human Nutrition and Food Science, Faculty of Agriculture and Food Sciences, Christian-Albrecht-University Kiel, Kiel, Germany
- 4Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
- 5German Center for Diabetes Research (DZD), München-Neuherberg, Germany
Time-restricted eating (TRE), a dietary approach limiting the daily eating window, has attracted increasing attention in media and research. The eating behavior in our modern society is often characterized by prolonged and erratic daily eating patterns, which might be associated with increased risk of obesity, diabetes, and cardiovascular diseases. In contrast, recent evidence suggests that TRE might support weight loss, improve cardiometabolic health, and overall wellbeing, but the data are controversial. The present work reviews how TRE affects glucose and lipid metabolism based on clinical trials published until June 2021. A range of trials demonstrated that TRE intervention lowered fasting and postprandial glucose levels in response to a standard meal or oral glucose tolerance test, as well as mean 24-h glucose and glycemic excursions assessed using continuous glucose monitoring. In addition, fasting insulin decreases and improvement of insulin sensitivity were demonstrated. These changes were often accompanied by the decrease of blood triglyceride and cholesterol levels. However, a number of studies found that TRE had either adverse or no effects on glycemic and lipid traits, which might be explained by the different study designs (i.e., fasting/eating duration, daytime of eating, changes of calorie intake, duration of intervention) and study subject cohorts (metabolic status, age, gender, chronotype, etc.). To summarize, TRE represents an attractive and easy-to-adapt dietary strategy for the prevention and therapy of glucose and lipid metabolic disturbances. However, carefully controlled future TRE studies are needed to confirm these effects to understand the underlying mechanisms and assess the applicability of personalized interventions.
Introduction
A growing body of evidence suggests that our circadian clock tightly interacts with metabolic functions (1) and that meal timing is an important factor for metabolic regulation (2–4). Chrononutrition, a novel discipline investigating the relation between circadian rhythms, nutrition, and metabolism, has developed rapidly in recent years (5). Chrononutrition clearly demonstrated that when we eat is as critical as what and how much for the chronic disease progression (3). The eating behavior in our modern society is often characterized by prolonged and erratic daily eating patterns which, together with Western-type diet, sedentary lifestyle, and chronic sleep deprivation, might contribute to an increased risk of obesity, diabetes, and cardiovascular diseases (6). In contrast, time-restricted eating (TRE), a dietary approach limiting the daily eating window, has attracted an increasing attention as an easy-to-use tool supporting weight loss, improving cardiometabolic health, and overall wellbeing (7–9). However, clinical trials on TRE demonstrated controversial effects especially in regard to glycemic and lipid traits.
This review focuses on the impact of TRE on glucose and lipid metabolism based on the clinical trials published until June 2021. We will also discuss different aspects of the TRE study design and different characteristics of study subjects as possible reasons for result bias. Further, we will shortly address molecular and physiological mechanisms of TRE effects. Finally, we will debate research gaps, which have to be filled by future studies and discuss the potential of TRE for the prevention and therapy of metabolic diseases.
Tight Interaction of Circadian Clock and Metabolism
The endogenous circadian clock has been widely accepted to play an important role in the adaptation of the physiology and behavior of living organisms to the day-night changes, including in humans. In particular, circadian rhythms with a period of approximately 24 h regulate the metabolism of humans by synchronization of metabolic pathways, detaching non-compatible physiological and biochemical mechanisms, as well as improving the energy expenditure (1). In humans, circadian dysruptions resulting from shift work or chronic jet lag are related to obesity, metabolic syndrome, and cardiovascular diseases, which are consequences of an unbalanced metabolic homeostasis (10–12). Similar results were observed in animals with genetic knockout of key clock genes (13, 14). This leads to the assumption that metabolic health is preserved by proper functioning of circadian clocks. In turn, obesity and metabolic diseases, e.g., type 2 diabetes, alter or blunt circadian rhythms (15–17), confirming a tight reciprocal interaction of circadian clock and metabolism.
The circadian clock, in mammals, includes a master and a peripheral clock (1). The master clock is located at the hypothalamus in the suprachiasmatic nucleus (SCN). Peripheral oscillators orchestrated by the master clock are present in nearly every tissue, including metabolically active organs, such as the liver, adipose tissue, pancreas, and skeletal muscle. The molecular clock mechanism existing in almost every cell consists of interlocked transcriptional-translational feedback loops (2), including transcription factors aryl hydrocarbon receptor nuclear translocator, like (ARNTL, also known as BMAL1), clock circadian regulator (CLOCK), period (PER1, PER2, PER3), cryptochrome (CRY1, CRY2), retinoic acid-related orphan receptors (RORs), and nuclear receptor subfamily 1 group D (NR1D1/2, also known as Rev-Erbα/ß). One cycle of this molecular machinery takes approximately 24 h and controls the expression of so-called clock-controlled genes (CCG), which include key metabolic transcription factors and enzymes generating circadian oscillations of metabolic functions (1, 2, 18). Indeed, 10% to 30% of the tissue transcriptome and 15% of circulating metabolome, as well as a number of circulating metabolic hormones—adipokines and cytokines involved in the regulation of carbohydrate, cholesterol, lipid, and energy metabolism—demonstrate circadian rhythms (19–24).
Notably, circadian clock itself undergoes metabolic and nutritional regulation. The reason is that food and feeding regimens are external cues (Zeitgeber), which can adjust (entrain) circadian rhythms in peripheral tissues. In mice fed with high-fat diet (HFD) and in mouse models of obesity, altered rhythms of core clock and a reorganisation of whole circadian transcriptome were observed (25–29). In humans, altered clock gene expression in human adipose tissue was found in obesity and metabolic syndrome (16, 17), and a blunted rhythm of clock gene expression in blood leucocytes was observed in type 2 diabetes (15). Our group showed in human intervention trials that both calorie intake and food composition affect circadian rhythms of clock and metabolic genes in blood monocytes and of circulating metabolic biomarkers (30, 31).
Role of Meal Timing in Metabolic Regulation
Because of the tight interaction between the circadian clock and metabolism, timing of eating is an important parameter for modulating body weight and metabolic state. First evidence was obtained in mouse studies showing that animal feeding in the light (i.e., inactive) phase leads to a desynchronization between peripheral tissues and the central clock and induces weight gain and metabolic disturbances (32–34).
Studies involving humans provide similar results. Shift work or chronic jetlag and, as a result, consuming meals at the “wrong” or unusual time increase the risk of developing type 2 diabetes, cardiovascular diseases, and obesity (3, 12). This could be, at least in part, due to a lifestyle-induced discrepancy between sleep/wake, as well as fasting/feeding phase and internal circadian cycles, which may result in disruption of the fatty acid metabolism, glucose intolerance, and dysregulation of the body clock transcriptome as confirmed by experimental human studies on circadian misalignment (35–37). To note, other confounding factors, like sleep deprivation, decreased physical activity, or an unhealthy diet, may also negatively influence metabolism in case of shift work.
Notably, experimental human studies identified that parameters like glucose tolerance, insulin sensitivity, beta-cell responsiveness, and postprandial thermogenesis show better profiles in the morning than in the evening or afternoon (35, 38, 39). We and others demonstrated that meal consumption in the morning results in lower postprandial glucose concentrations and altered secretions of insulin, C-peptide, and of the incretins glucagon-like peptide 1 (GLP1) and gastric inhibitory polypeptide (GIP) compared to the consumption of the same meal in the afternoon (39–41). In healthy adults, late dinner (10 PM) causes shift in the postprandial period, overlapping with the sleep phase (42). Independent of this shift, higher glucose, a triglyceride peak delay, and lower free fatty acids and dietary fatty acid oxidation in the postprandial period were observed. Interestingly, late dinner did not affect sleep architecture, but increased plasma cortisol. Disturbances in circadian rhythms (alterations in the daily patterns of body-temperature and cortisol) were similarly observed in school-aged children consuming late dinner (43). Notably, the delay of meal timing or even change of the timely distribution of the calorie intake within the day without changing of sleeping times can shift expression rhythms of key clock genes in adipose tissue and blood cells (37, 44), possibly via postprandial hormone and metabolite changes.
In agreement with this, several human studies show that the timing of meals influences the outcome of weight loss therapy. Individuals consuming their lunch in the late hours lost less weight than the early eaters, although both groups consumed a hypocaloric diet (45). High caloric intake during breakfast has a positive effect on hunger scores, weight, as well as glucose, insulin, and ghrelin concentrations in comparison to the same intake during dinner (46). Late and delayed eating is associated with weight gain, dysfunction in energy expenditure, and abnormalities in the circadian rhythms of appetite, stress, and sleep hormones in most reports (47), although some epidemiological studies do not confirm these effects (48, 49). Notably, the night-eating syndrome clearly correlates with obesity (42). Furthermore, several experimental human studies show that eating in the evening worsens metabolic parameters in comparison with the improvement in daytime eaters (50–54).
Interestingly, novel studies suggest that certain time windows are more suitable for the consumption of certain kinds of food to maintain metabolic health. We recently showed that a consumption of high carb meals in the evening (in combination with high-fat meals in the morning) induces higher blood glucose levels and worsen glycemic control in subjects with an impaired glucose metabolism compared with a reverse pattern of meal composition (39). In agreement with this, epidemiological human studies report the positive effect of morning carbohydrate intake on the prevention of metabolic disorders (55, 56). Moreover, timing of carbohydrates and fat intake also affected circulating adipokine concentrations (57) and diurnal variation of the plasma lipidome (20).
Taken together, most published studies suggest that early eating is in alignment with our metabolic clock and therefore might be beneficial for metabolic health.
Time-Restricted Eating: Idea, Definition, and Overview of Effects
In our modern society, prolonged and erratic daily eating patterns often take place. In American and Indian adults, eating periods of 15 h or longer every day were observed in more than half of the individuals. In addition, more than a third of the daily caloric intake occurred in the evening (6, 58). This eating period is often shifted to a later time on weekends indicating a “social jet lag” (59). Notably, reduction of the eating window in overweight individuals to 10 to 12 h resulted in sustained weight loss and improved subjective sleep quality after 16 weeks and 1 year of intervention (6). These data suggest that a shortening of the eating time and the accompanying elongation of the fasting time (≥ 12 h) might have beneficial effects on metabolic parameters in humans (60).
In the last years, time-restricted eating (TRE) has attracted increasing attention in public media as a strategy to lose weight and improve overall health. First data on TRE were collected in rodents where such diet is defined as “time-restricted feeding” (TRF). In mice, TRF increases the amplitude of circadian clock rhythms and is protective against HFD-induced obesity, glucose intolerance, leptin resistance, hepatic steatosis, and tissue inflammation compared with ad libitum HFD feeding (26, 61).
In humans, the increased research interest to TRE initiated a number of intervention trials evaluating the effects of several TRE regimens with daily eating periods between 4 and 11 h on healthy individuals or participants with metabolic abnormalities (summarized in the Table 1). Most of them were short-term trials (4 days to 12 weeks) conducted in a relatively small number of subjects (8 to 80 participants) except for the study by Cai et al. with 174 subjects (63). In these studies, TRE not only appears to be a well-tolerated treatment strategy for overweight and obese patients but also generates beneficial metabolic effects (7, 59) (Figure 1), as discussed below. Most TRE studies reported modest reduction of body weight (6, 63–66, 68, 71–75, 77, 78, 82, 83, 85, 86), overall and visceral fat (62–65, 72, 74, 77, 78, 85, 86), and waist circumference (72, 73, 83, 86), which could be partly explained by the self-reported reduction of energy intake observed in many trials (6, 65, 66, 71, 82, 86, 87). Unexpectedly, TRE decreased feeling of hunger and desire to eat (76, 79, 80, 84) and the level of hunger hormone ghrelin (69, 70), although in one study fasting ghrelin level was increased (71) (Table 1). The data on satiety hormones, PYY and leptin, are also inconsistent (69, 70, 84), whereas adiponectin was increased in two studies (77, 78). TRE also reduced inflammatory markers (74, 78), blood pressure (67, 77, 84, 86) and oxidative stress markers (65, 84). In several studies, subjects reported an improvement of sleep quality, quality of life, and felt more energetic at the end of the intervention (6, 88). However, one study found no TRE effect on the gut microbiome (67), whereas another trial observed higher microbial diversity (87). Interestingly, TRE also affected gene expression of markers of the circadian clock, aging, and autophagy (69, 87).
Table 1 Clinical trials on TRE with outcomes regarding glucose and lipid metabolism.
Figure 1 Beneficial effects of time-restricted eating (TRE) for individuals with metabolic disturbances. During TRE, elongation of the fasting period leads to the depletion of liver glycogen stores and a metabolic switch from lipid/cholesterol synthesis and fat storage to mobilization of fat through fatty acid oxidation and fatty acid-derived ketones. Modification of fasting–eating cycle can also directly influence peripheral clock which in turn contribute to the metabolic changes. The clock entrainment in peripheral tissues can be induced by the time shift of postprandial changes of metabolic hormones and nutrients acting via a number of molecular pathways as well as by the alterations of AMP/ATP ratio and cellular NAD+ availability.
Furthermore, many TRE trials demonstrated improvement of glucose metabolism and blood lipids, whereas other studies found no or adverse effects of TRE on glycemic and lipid traits which will be discussed in detail in the next two chapters.
Effects of TRE on Glucose Metabolism
Eight studies revealed positive changes in glucose levels because of TRE (62, 64, 68, 69, 76, 78, 80, 82), although this was not universally observed (63, 65, 66, 72, 74, 75, 77, 79, 83, 85). Nonetheless, TRE interventions significantly lowered fasting glucose levels (62, 64, 69, 78, 82), postprandial glucose levels in response to a standard meal or oral glucose tolerance test (OGTT) (68, 76), and night-time glucose (80). Few TRE trials applied continuous glucose monitoring (CGM) to monitor the glucose concentration over the 24 h per day as opposed to only certain time points. The beneficial effects appear even in CGM data, e.g., decreased mean 24-h glucose, glycemic excursions (69), and mean fasting glucose (68). HbA1c, as an important indicator of long-term glycemic control, decreased in two trials after TRE intervention in overweight and obese participants (73, 86), whereas no changes were detected in three other studies (75, 79, 83). Moreover, TRE could be shown to significantly lower fasting insulin levels, as well as insulin resistance (65, 69, 74, 78, 84) and increase insulin sensitivity (71, 84). Again, these results are not consistent in all conducted studies as other TRE interventions had no notable effect on insulin levels or insulin resistance (63, 66, 68, 72, 75–77, 79, 80, 85).
Improvement of glucose metabolism with TRE could be, at least in part, due to caloric restriction and associated weight loss (7, 8) (Table 1). Nevertheless, four TRE trials revealed beneficial effects on the glucose metabolism, regardless of caloric restriction or weight loss (62, 69, 76, 84). These findings suggest that the TRE dietary habit could produce positive metabolic effects, independent of energy balance.
Effects of TRE on Lipid Metabolism
Observed effects of TRE on plasma lipid levels are highly variable. Therefore, the triglyceride (TG) levels decreased significant in five TRE-studies (63, 64, 68, 78, 87), whereas no significant changes in TG levels occurred in 12 other studies (65, 66, 69, 71, 73–75, 77, 79, 83, 85, 86), and in two isocaloric trials, the fasting TG concentration actually increased (72, 84). Concerning cholesterol levels (total, HDL and LDL), the current state of improvements through TRE is inconsistent. In most TRE interventions, no significant changes of cholesterol levels emerged (Table 1). Nevertheless, in some cases, the shortened time of caloric intake improved participants cholesterol levels, by either decreasing total cholesterol and LDL (86, 87) or notably increasing HDL blood concentrations (77, 87). Contrarily, in one study, the TRE protocol leads to an increase of total and LDL cholesterol (76). Similar to glucose metabolism, TRE can affect lipid metabolism regardless of weight loss/caloric restriction (76, 84, 87).
The present work indicates that the effects of TRE on glycemic control are apparently less variable than effects of TRE on plasma lipid profiles. One possible explanation of this phenomenon might be the known diurnal rhythm of glucose tolerance, which decreases from morning to evening and night, whereas it is established that lipid circadian rhythms show substantial inter-individual variability (89).
Current Research Gaps and Open Questions
Taken together, TRE represents a promising and simple dietary approach for the prevention and therapy of disturbances in glucose and lipid metabolism (e.g., obesity, type 2 diabetes, metabolic syndrome, etc.) in the general population (because it does not require extensive nutritional knowledge) and medical practice. Published TRE studies included several different subject groups varying from lean and healthy adults (62, 71, 76–78, 87), overweight, and obese subjects (64–66, 69, 70, 72, 73, 75, 80, 82) up to adult individuals with metabolic disturbances such as prediabetes (68, 84), type 2 diabetes (79), metabolic syndrome (83, 86), or NAFLD (63). These discrepancies between study participants should be noted as it is more likely to observe metabolic benefits in cohorts with obesity or pre-existing disturbances of lipid and/or glucose metabolism compared to healthy lean adults. However, some studies reported metabolic improvements also in healthy subjects, e.g., improved glucose levels, insulin sensitivity (71, 78), or blood lipid levels (77, 78, 87), indicating that TRE could be beneficial even for healthy individuals. However, there are some groups of individuals for which the TRE may not be appropriate for, e.g., children and teenagers who are actively growing, subjects taking drugs or insulin injections to lower blood sugar, especially people with type 1 diabetes, subjects with acute illness, eating disorders, pregnancy or are breastfeeding, as well as individuals with severe kidney and liver diseases and cancer. TRE might be harmful to these subjects, consequently they should consider TRE only in consultation with and supervision by a physician.
Further, there is a range of research gaps and open questions in this field of TRE research, which need further investigation. The main question raised is the reason for the inconsistencies in metabolic outcomes between TRE studies. This might be explained by the different study designs (e.g., fasting/eating duration, daytime of eating, changes of calorie intake, duration of intervention) and study subject cohorts (metabolic status, age, gender, chronotype, etc.) as already mentioned above. The next important limitation is that the wide spectrum of TRE regimens with daily eating periods between 4 and 11 h and food consumption early (eTRF) or late in the day (lTRE) makes the dietary effects scarcely comparable. In particular, optimal duration of the eating window is unknown, suggesting that a direct comparison of varying eating windows (e.g., 6 h vs 9 h vs. 12 h) has to be performed in the future studies upon the careful controlling of caloric intake as discussed below.
Early morning is likely to be an optimal TRE time to induce maximal metabolic benefits. In most eTRE studies, restricting food intake to the morning resulted in an improvement of insulin sensitivity, beta-cell responsiveness, blood pressure, inflammation, and oxidative stress (69–71, 84). In contrast, on lTRE, restricting food intake to the late afternoon or evening (after 4 PM) did not change or even worsen blood glucose, beta-cell responsiveness, and lipid levels (65, 75, 76, 78, 85). Notably, until now, only one study directly compared eTRE and lTRE in a cross-over design (68) where postprandial glucose and fasting triglycerides decreased after consuming both diets, whereas mean fasting glucose assessed by CGM improved only with eTRE. Trials in which eating window was restricted to the middle of the day or self-defined window but was not precisely matched, resulted in a reduced body weight or fat mass, with contradictory results concerning fasting glucose, insulin, and lipids (6, 66, 80, 81, 86). This, in combination with generally small sample sizes (and correspondingly low power) and lack of long-term interventions makes published results hard to interpret and to formulate dietary recommendations.
In most trials that investigated TRE under free-living conditions, participants were adherent to the prescribed eating windows on more than 80% of days throughout the intervention period (63–66, 71, 73, 75, 76, 86). Only Parr et al. (79) reported adherence rates to a 9-h TRE intervention to be minimally lower, with 72 ± 24%. In summary, the adherence to TRE over short periods is high, suggesting that TRE is a feasible and easy-to-adapt dietary strategy. However, the long-term practicality of a dietary approach is crucial for beneficial health outcomes (90), and therefore, future trials should examine the adherence to TRE in real life settings over longer periods.
Notably, implementing of eTRE may be challenging for general population because the meals in the evening, consumed after work, are an important family and social event. Late TRE leading to skip breakfast would be better compatible with social life, but is less effective or can even induce adverse metabolic effects as mentioned above. Moreover, shifting of the meal time to a later time of day can induce clock phase delay in peripheral tissues (50); however, metabolic consequences still needs to be further investigated. Thus, timing of meals is considerably associated with quality of life and TRE adherence. Until now, only several trials analyzed individual’s life quality on TRE and reported its improvement when using self-defined eating windows (6, 88). Future studies comparing effects of various TRE windows on the life quality are needed. The next question is whether individual’s chronotype has to be considered when prescribing optimal eating times. Chronotype is a behavioral manifestation of an individual’s internal clock; and late chronotype (“owls”) and early chronotype (“larks”) are the two extremes which strongly differ in peak times of metabolic function, body temperature, cognitive faculties, and sleeping (59) as well as eating habits (91, 92). Whether late chronotypes can profit in the same matter from the eTRE as early chronotypes or the lTRE is more suitable for such individuals also needs future investigation.
The further important question is whether beneficial metabolic effects of TRE and even the weight loss are resulting from the reduction of energy intake alone or also from the shortening of the eating window (and corresponding prolongation of fasting). Most published trials reported a reduction of energy intake because individuals are often not able to consume all usual food quantity within the limited time window. Nevertheless, four carefully controlled or short-term (4–5 days) TRE trials revealed beneficial effects on the glucose metabolism without caloric restriction or weight loss (62, 69, 76, 84), suggesting that timing factor alone can improve metabolic state. Further, most of the published human TRE studies did not carefully monitor dietary macronutrient content, which could lead to false data interpretation, e.g., if subjects have to skip high-fat or sweet snacks or alcohol drinks often consumed in the evening.
This opens a next question concerning physiological and molecular mechanisms underlying metabolic TRE effects. One possible explanation of this effect might be the elongation of the fasting period (typically beyond 12 h), which leads to the depletion of liver glycogen stores and a metabolic switch from lipid/cholesterol synthesis and fat storage to mobilization of fat through fatty acid oxidation and fatty acid-derived ketones (60). Further, prolonged fasting might improve metabolism and reduce oxidative stress via autophagy activation, although relevant publications are sparse. In rodents, intermittent fasting regimen with 24-h fasting periods preserved beta-cell mass in obesity-induced diabetes via the autophagy–lysosome pathway (93) and a similar mechanism might work for shorter fasting duration. In humans, only one study investigated TRE effects on autophagy genes and found changes of LC3A and ATG12 expression in whole blood (69). Some data also suggest that the modification of fasting–eating cycle is likely to influence peripheral clock itself which in turn contribute to the metabolic changes. The clock entrainment in peripheral tissues such as liver or adipose tissue can be induced by postprandial changes of metabolic hormones, i.e., insulin and oxyntomodulin (94, 95). Moreover, the postprandial increase of glucose, lipids, and amino acids may affect the circadian clock via key intracellular metabolic sensors such as SIRT1, mTOR, S6K, AMPK, PPARs, RORs, and Rev-Erbs (96). In particular, fasting increases AMP/ATP ratio and cellular availability of NAD+, regulating clock machinery via AMPK and SIRT1, respectively (8). Notably, the careful timing of the physical activity in the context of TRE could intensify its metabolic effects because several common mechanisms are activated by exercise and prolonged fasting (97). However, most of these mechanisms were described in rodents and require intensive investigation in human TRE studies. In particular, it is unknown whether eTRE is more beneficial than lTRE for the synchronization and improvement of clock rhythms in humans. Further analyses of novel biomarkers (e.g., adipokines, cytokines, oxidative stress markers, gene expression in muscle or adipose tissue) and using modern techniques and portable devices for the continuous monitoring of glucose, physical activity, sleep quality, and food intake (e.g. using smartphones) would provide new data on physiological and molecular mechanisms induced by TRE.
Taken together, further human trials are needed to investigate effects of TRE: (1) carefully monitoring macronutrient and calorie intake (possibly via conducting an isocaloric TRE); (2) directly comparing effects of eTRE and lTRE; (3) comparing varying eating window duration; (4) in long-term studies; (5) in a large number of study participants; (6) comparing TRE effects in subjects with different chronotypes; (7) including analyses of physiological and molecular mechanisms underlying the TRE-induced changes. In particular, calling for research that balances feasibility of TRE interventions (e.g., timing and duration of eating windows) with long-term adherence and metabolic benefits could be recommended.
Confirming a large scientific and practical interest to the TRE approach, there are more than 20 ongoing intervention trials applying TRE approaches to improve body weight and metabolic state of individuals as based on published study protocols and a search in ClinicalTrials.gov database. A few trials will be conducted in larger cohorts with more than 100 participants, however several trials are planned in smaller cohorts with well-defined participants, e.g., with specific medical conditions linked to obesity. Moreover, most interventions are still short term with intervention periods lasting 2 to 12 weeks, and only eight studies scheduled longer interventions (up to 1 year). Solely, four trials will be directly comparing TRE at different daytimes. Moreover, none of the ongoing trials aims to compare TRE in individuals with different chronotypes, although the subjects’ chronotype will be assessed in several studies. In consequence, even though many TRE trials are ongoing, it remains unclear if these trials will be sufficient to answer all the abovementioned research gaps and formulate dietary recommendations for the general public.
Conclusions and Perspectives
TRE represents an attractive and easy-to-adapt dietary strategy for the prevention and therapy of glucose and lipid metabolic disturbances. It might be widely used to restore disturbed circadian rhythms and to improve metabolic health in obesity, insulin resistance, metabolic syndrome, and cardiovascular diseases. In the best way, TRE approach has to be used in combination with healthy dietary composition, an increased physical activity, and adequate sleep quality and duration to support optimal health. However, future carefully controlled TRE studies are needed to formulate dietary recommendations for the general population and medical practice.
Author Contributions
OP-R generated the idea and performed the supervision of the manuscript preparation. All authors contributed to the article and approved the submitted version.
Funding
The study was supported by a grant of the German Science Foundation (DFG RA 3340/3-1 OP-R), of the German Diabetic Association (Allgemeine Projektförderung der DDG 2020, OP-R; and Adam-Heller-Projektförderung der DDG/Abbott, 2021, OP-R), and by the Morgagni Prize of the European Association of Study of Diabetes 2020 (OP-R).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Acknowledgments
We thank C. A. Bishop (Department of Physiology of Energy Metabolism, German Institute of Human Nutrition, Germany) for language proof-reading of the manuscript.
References
1. Panda S. Circadian Physiology of Metabolism. Science (2016) 354:1008–15. doi: 10.1126/science.aah4967
2. Asher G, Sassone-Corsi P. Time for Food: The Intimate Interplay Between Nutrition, Metabolism, and the Circadian Clock. Cell (2015) 161:84–92. doi: 10.1016/j.cell.2015.03.015
3. Jiang P, Turek FW. Timing of Meals: When Is as Critical as What and How Much. Am J Physiol Endocrinol Metab (2017) 312:E369–80. doi: 10.1152/ajpendo.00295.2016
4. Kessler K, Pivovarova-Ramich O. Meal Timing, Aging, and Metabolic Health. Int J Mol Sci (2019) 20:1911. doi: 10.3390/ijms20081911
5. Johnston JD, Ordovas JM, Scheer FA, Turek FW. Circadian Rhythms, Metabolism, and Chrononutrition in Rodents and Humans. Adv Nutr (2016) 7:399–406. doi: 10.3945/an.115.010777
6. Gill S, Panda S. A Smartphone App Reveals Erratic Diurnal Eating Patterns in Humans That Can Be Modulated for Health Benefits. Cell Metab (2015) 22:789–98. doi: 10.1016/j.cmet.2015.09.005
7. Adafer R, Messaadi W, Meddahi M, Patey A, Haderbache A, Bayen S, et al. Food Timing, Circadian Rhythm and Chrononutrition: A Systematic Review of Time-Restricted Eating’s Effects on Human Health. Nutrients (2020) 12:3770. doi: 10.3390/nu12123770
8. Regmi P, Heilbronn LK. Time-Restricted Eating: Benefits, Mechanisms, and Challenges in Translation. iScience (2020) 23:101161. doi: 10.1016/j.isci.2020.101161
9. Chaix A, Manoogian ENC, Melkani GC, Panda S. Time-Restricted Eating to Prevent and Manage Chronic Metabolic Diseases. Annu Rev Nutr (2019) 39:291–315. doi: 10.1146/annurev-nutr-082018-124320
10. Vetter C, Devore EE, Wegrzyn LR, Massa J, Speizer FE, Kawachi I, et al. Association Between Rotating Night Shift Work and Risk of Coronary Heart Disease Among Women. JAMA J Am Med Assoc (2016) 315:1726–34. doi: 10.1001/jama.2016.4454
11. De Bacquer D, Van Risseghem M, Clays E, Kittel F, De Backer G, Braeckman L. Rotating Shift Work and the Metabolic Syndrome: A Prospective Study. Int J Epidemiol (2009) 38:848–54. doi: 10.1093/ije/dyn360
12. Antunes LC, Levandovski R, Dantas G, Caumo W, Hidalgo MP. Obesity and Shift Work: Chronobiological Aspects. Nutr Res Rev (2010) 23:155–68. doi: 10.1017/S0954422410000016
13. Turek FW. Obesity and Metabolic Syndrome in Circadian Clock Mutant Mice. Science (2005) 308:1043–5. doi: 10.1126/science.1108750
14. Paschos GK, Ibrahim S, Song WL, Kunieda T, Grant G, Reyes TM, et al. Obesity in Mice With Adipocyte-Specific Deletion of Clock Component Arntl. Nat Med (2012) 18:1768–77. doi: 10.1038/nm.2979
15. Ando H, Takamura T, Matsuzawa-Nagata N, Shima KR, Eto T, Misu H, et al. Clock Gene Expression in Peripheral Leucocytes of Patients With Type 2 Diabetes. Diabetologia (2009) 52:329–35. doi: 10.1007/s00125-008-1194-6
16. Vieira E, Ruano E, Figueroa AL, Aranda G, Momblan D, Carmona F, et al. Altered Clock Gene Expression in Obese Visceral Adipose Tissue Is Associated With Metabolic Syndrome. PloS One (2014) 9:e111678. doi: 10.1371/journal.pone.0111678
17. Gomez-Abellan P, Hernandez-Morante JJ, Lujan JA, Madrid JA, Garaulet M. Clock Genes Are Implicated in the Human Metabolic Syndrome. Int J Obes (Lond) (2008) 32:121–8. doi: 10.1038/sj.ijo.0803689
18. Brown SA. Circadian Metabolism: From Mechanisms to Metabolomics and Medicine. Trends Endocrinol Metabolism: TEM (2016) 27:415–26. doi: 10.1016/j.tem.2016.03.015
19. Keller M, Mazuch J, Abraham U, Eom GD, Herzog ED, Volk HD, et al. A Circadian Clock in Macrophages Controls Inflammatory Immune Responses. Proc Natl Acad Sci USA (2009) 106:21407–12. doi: 10.1073/pnas.0906361106
20. Kessler K, Gerl MJ, Hornemann S, Damm M, Klose C, Petzke KJ, et al. Shotgun Lipidomics Discovered Diurnal Regulation of Lipid Metabolism Linked to Insulin Sensitivity in Nondiabetic Men. J Clin Endocrinol Metab (2020) 105:dgz176. doi: 10.1210/clinem/dgz176
21. Held NM, Wefers J, van Weeghel M, Daemen S, Hansen J, Vaz FM, et al. Skeletal Muscle in Healthy Humans Exhibits a Day-Night Rhythm in Lipid Metabolism. Mol Metab (2020) 37:100989. doi: 10.1016/j.molmet.2020.100989
22. Loboda A, Kraft WK, Fine B, Joseph J, Nebozhyn M, Zhang C, et al. Diurnal Variation of the Human Adipose Transcriptome and the Link to Metabolic Disease. BMC Med Genomics (2009) 2:7. doi: 10.1186/1755-8794-2-7
23. Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA. The Human Circadian Metabolome. Proc Natl Acad Sci USA (2012) 109:2625–9. doi: 10.1073/pnas.1114410109
24. Christou S, Wehrens SMT, Isherwood C, Moller-Levet CS, Wu H, Revell VL, et al. Circadian Regulation in Human White Adipose Tissue Revealed by Transcriptome and Metabolic Network Analysis. Sci Rep (2019) 9:2641. doi: 10.1038/s41598-019-39668-3
25. Kohsaka A, Laposky AD, Ramsey KM, Estrada C, Joshu C, Kobayashi Y, et al. High-Fat Diet Disrupts Behavioral and Molecular Circadian Rhythms in Mice. Cell Metab (2007) 6:414–21. doi: 10.1016/j.cmet.2007.09.006
26. Hatori M, Vollmers C, Zarrinpar A, DiTacchio L, Bushong EA, Gill S, et al. Time-Restricted Feeding Without Reducing Caloric Intake Prevents Metabolic Diseases in Mice Fed a High-Fat Diet. Cell Metab (2012) 15:848–60. doi: 10.1016/j.cmet.2012.04.019
27. Eckel-Mahan KL, Patel VR, de Mateo S, Orozco-Solis R, Ceglia NJ, Sahar S, et al. Reprogramming of the Circadian Clock by Nutritional Challenge. Cell (2013) 155:1464–78. doi: 10.1016/j.cell.2013.11.034
28. Su W, Xie Z, Guo Z, Duncan MJ, Lutshumba J, Gong MC. Altered Clock Gene Expression and Vascular Smooth Muscle Diurnal Contractile Variations in Type 2 Diabetic Db/Db Mice. Am J Physiol Heart Circulatory Physiol (2012) 302:H621–633. doi: 10.1152/ajpheart.00825.2011
29. Ando H, Kumazaki M, Motosugi Y, Ushijima K, Maekawa T, Ishikawa E, et al. Impairment of Peripheral Circadian Clocks Precedes Metabolic Abnormalities in Ob/Ob Mice. Endocrinology (2011) 152:1347–54. doi: 10.1210/en.2010-1068
30. Pivovarova O, Gogebakan O, Sucher S, Groth J, Murahovschi V, Kessler K, et al. Regulation of the Clock Gene Expression in Human Adipose Tissue by Weight Loss. Int J Obes (Lond) (2016) 40:899–906. doi: 10.1038/ijo.2016.34
31. Pivovarova O, Jurchott K, Rudovich N, Hornemann S, Ye L, Mockel S, et al. Changes of Dietary Fat and Carbohydrate Content Alter Central and Peripheral Clock in Humans. J Clin Endocrinol Metab (2015) 100:2291–302. doi: 10.1210/jc.2014-3868
32. Damiola F. Restricted Feeding Uncouples Circadian Oscillators in Peripheral Tissues From the Central Pacemaker in the Suprachiasmatic Nucleus. Genes Dev (2000) 14:2950–61. doi: 10.1101/gad.183500
33. Arble DM, Bass J, Laposky AD, Vitaterna MH, Turek FW. Circadian Timing of Food Intake Contributes to Weight Gain. Obes (Silver Spring) (2009) 17:2100–2. doi: 10.1038/oby.2009.264
34. Fonken LK, Workman JL, Walton JC, Weil ZM, Morris JS, Haim A, et al. Light at Night Increases Body Mass by Shifting the Time of Food Intake. Proc Natl Acad Sci USA (2010) 107:18664–9. doi: 10.1073/pnas.1008734107
35. Scheer FA, Hilton MF, Mantzoros CS, Shea SA. Adverse Metabolic and Cardiovascular Consequences of Circadian Misalignment. Proc Natl Acad Sci USA (2009) 106:4453–8. doi: 10.1073/pnas.0808180106
36. Archer SN, Laing EE, Moller-Levet CS, van der Veen DR, Bucca G, Lazar AS, et al. Mistimed Sleep Disrupts Circadian Regulation of the Human Transcriptome. Proc Natl Acad Sci USA (2014) 111:E682–691. doi: 10.1073/pnas.1316335111
37. Wefers J, van Moorsel D, Hansen J, Connell NJ, Havekes B, Hoeks J, et al. Circadian Misalignment Induces Fatty Acid Metabolism Gene Profiles and Compromises Insulin Sensitivity in Human Skeletal Muscle. Proc Natl Acad Sci USA (2018) 115:7789–94. doi: 10.1073/pnas.1722295115
38. Bo S, Fadda M, Castiglione A, Ciccone G, De Francesco A, Fedele D, et al. Is the Timing of Caloric Intake Associated With Variation in Diet-Induced Thermogenesis and in the Metabolic Pattern? A Randomized Cross-Over Study. Int J Obes (Lond) (2015) 39:1689–95. doi: 10.1038/ijo.2015.138
39. Kessler K, Hornemann S, Petzke KJ, Kemper M, Kramer A, Pfeiffer AF, et al. The Effect of Diurnal Distribution of Carbohydrates and Fat on Glycaemic Control in Humans: A Randomized Controlled Trial. Sci Rep (2017) 7:44170. doi: 10.1038/srep44170
40. Jakubowicz D, Wainstein J, Ahren B, Bar-Dayan Y, Landau Z, Rabinovitz HR, et al. High-Energy Breakfast With Low-Energy Dinner Decreases Overall Daily Hyperglycaemia in Type 2 Diabetic Patients: A Randomised Clinical Trial. Diabetologia (2015) 58:912–9. doi: 10.1007/s00125-015-3524-9
41. Lindgren O, Mari A, Deacon CF, Carr RD, Winzell MS, Vikman J, et al. Differential Islet and Incretin Hormone Responses in Morning Versus Afternoon After Standardized Meal in Healthy Men. J Clin Endocrinol Metab (2009) 94:2887–92. doi: 10.1210/jc.2009-0366
42. Gu C, Brereton N, Schweitzer A, Cotter M, Duan D, Borsheim E, et al. Metabolic Effects of Late Dinner in Healthy Volunteers-A Randomized Crossover Clinical Trial. J Clin Endocrinol Metab (2020) 105:2789–802. doi: 10.1210/clinem/dgaa354
43. Martinez-Lozano N, Tvarijonaviciute A, Rios R, Baron I, Scheer F, Garaulet M. Late Eating Is Associated With Obesity, Inflammatory Markers and Circadian-Related Disturbances in School-Aged Children. Nutrients (2020) 12:2881. doi: 10.3390/nu12092881
44. Jakubowicz D, Landau Z, Tsameret S, Wainstein J, Raz I, Ahren B, et al. Reduction in Glycated Hemoglobin and Daily Insulin Dose Alongside Circadian Clock Upregulation in Patients With Type 2 Diabetes Consuming a Three-Meal Diet: A Randomized Clinical Trial. Diabetes Care (2019) 42:2171–80. doi: 10.2337/dc19-1142
45. Garaulet M, Gomez-Abellan P, Alburquerque-Bejar JJ, Lee YC, Ordovas JM, Scheer FA. Timing of Food Intake Predicts Weight Loss Effectiveness. Int J Obes (Lond) (2013) 37:604–11. doi: 10.1038/ijo.2012.229
46. Jakubowicz D, Barnea M, Wainstein J, Froy O. High Caloric Intake at Breakfast vs. Dinner Differentially Influences Weight Loss of Overweight and Obese Women. Obes (Silver Spring) (2013) 21:2504–12. doi: 10.1002/oby.20460
47. Allison KC, Goel N. Timing of Eating in Adults Across the Weight Spectrum: Metabolic Factors and Potential Circadian Mechanisms. Physiol Behav (2018) 192:158–66. doi: 10.1016/j.physbeh.2018.02.047
48. Sandhu SK, Tang TS. When’s Dinner? Does Timing of Dinner Affect the Cardiometabolic Risk Profiles of South-Asian Canadians at Risk for Diabetes. Diabetes Med (2017) 34:539–42. doi: 10.1111/dme.13081
49. Aljuraiban GS, Chan Q, Oude Griep LM, Brown IJ, Daviglus ML, Stamler J, et al. The Impact of Eating Frequency and Time of Intake on Nutrient Quality and Body Mass Index: The INTERMAP Study, a Population-Based Study. J Acad Nutr Diet (2015) 115:528–536 e521. doi: 10.1016/j.jand.2014.11.017
50. Wehrens SMT, Christou S, Isherwood C, Middleton B, Gibbs MA, Archer SN, et al. Meal Timing Regulates the Human Circadian System. Curr Biol CB (2017) 27:1768–1775 e1763. doi: 10.1016/j.cub.2017.04.059
51. LeCheminant JD, Christenson E, Bailey BW, Tucker LA. Restricting Night-Time Eating Reduces Daily Energy Intake in Healthy Young Men: A Short-Term Cross-Over Study. Br J Nutr (2013) 110:2108–13. doi: 10.1017/S0007114513001359
52. Hibi M, Masumoto A, Naito Y, Kiuchi K, Yoshimoto Y, Matsumoto M, et al. Nighttime Snacking Reduces Whole Body Fat Oxidation and Increases LDL Cholesterol in Healthy Young Women. Am J Physiol Regulatory Integr Comp Physiol (2013) 304:R94–R101. doi: 10.1152/ajpregu.00115.2012
53. Bandin C, Scheer FA, Luque AJ, Avila-Gandia V, Zamora S, Madrid JA, et al. Meal Timing Affects Glucose Tolerance, Substrate Oxidation and Circadian-Related Variables: A Randomized, Crossover Trial. Int J Obes (Lond) (2015) 39:828–33. doi: 10.1038/ijo.2014.182
54. Qin LQ, Li J, Wang Y, Wang J, Xu JY, Kaneko T. The Effects of Nocturnal Life on Endocrine Circadian Patterns in Healthy Adults. Life Sci (2003) 73:2467–75. doi: 10.1016/S0024-3205(03)00628-3
55. Almoosawi S, Prynne CJ, Hardy R, Stephen AM. Diurnal Eating Rhythms: Association With Long-Term Development of Diabetes in the 1946 British Birth Cohort. Nutr Metab Cardiovasc Dis (2013) 23:1025–30. doi: 10.1016/j.numecd.2013.01.003
56. Almoosawi S, Prynne CJ, Hardy R, Stephen AM. Time-Of-Day and Nutrient Composition of Eating Occasions: Prospective Association With the Metabolic Syndrome in the 1946 British Birth Cohort. Int J Obes (Lond) (2013) 37:725–31. doi: 10.1038/ijo.2012.103
57. Kessler K, Hornemann S, Petzke KJ, Kemper M, Markova M, Rudovich N, et al. Diurnal Distribution of Carbohydrates and Fat Affects Substrate Oxidation and Adipokine Secretion in Humans. Am J Clin Nutr (2018) 108:1209–19. doi: 10.1093/ajcn/nqy224
58. Gupta NJ, Kumar V, Panda S. A Camera-Phone Based Study Reveals Erratic Eating Pattern and Disrupted Daily Eating-Fasting Cycle Among Adults in India. PloS One (2017) 12:e0172852. doi: 10.1371/journal.pone.0172852
59. Roenneberg T, Allebrandt KV, Merrow M, Vetter C. Social Jetlag and Obesity. Curr Biol CB (2012) 22:939–43. doi: 10.1016/j.cub.2012.03.038
60. Anton SD, Moehl K, Donahoo WT, Marosi K, Lee SA, Mainous AG 3rd, et al. Flipping the Metabolic Switch: Understanding and Applying the Health Benefits of Fasting. Obes (Silver Spring) (2018) 26:254–68. doi: 10.1002/oby.22065
61. Chaix A, Zarrinpar A, Miu P, Panda S. Time-Restricted Feeding Is a Preventative and Therapeutic Intervention Against Diverse Nutritional Challenges. Cell Metab (2014) 20:991–1005. doi: 10.1016/j.cmet.2014.11.001
62. Antoni R, Robertson T, Robertson M, Johnston J. A Pilot Feasibility Study Exploring the Effects of a Moderate Time-Restricted Feeding Intervention on Energy Intake, Adiposity and Metabolic Physiology in Free-Living Human Subjects. J Nutr Sci (2018) 7:e22. doi: 10.1017/jns.2018.13
63. Cai H, Qin YL, Shi ZY, Chen JH, Zeng MJ, Zhou W, et al. Effects of Alternate-Day Fasting on Body Weight and Dyslipidaemia in Patients With Non-Alcoholic Fatty Liver Disease: A Randomised Controlled Trial. BMC Gastroenterol (2019) 19:219. doi: 10.1186/s12876-019-1132-8
64. Chow LS, Manoogian ENC, Alvear A, Fleischer JG, Thor H, Dietsche K, et al. Time-Restricted Eating Effects on Body Composition and Metabolic Measures in Humans Who are Overweight: A Feasibility Study. Obes (Silver Spring) (2020) 28:860–9. doi: 10.1002/oby.22756
65. Cienfuegos S, Gabel K, Kalam F, Ezpeleta M, Wiseman E, Pavlou V, et al. Effects of 4- and 6-H Time-Restricted Feeding on Weight and Cardiometabolic Health: A Randomized Controlled Trial in Adults With Obesity. Cell Metab (2020) 32:366–78.e363. doi: 10.1016/j.cmet.2020.06.018
66. Gabel K, Hoddy KK, Haggerty N, Song J, Kroeger CM, Trepanowski JF, et al. Effects of 8-Hour Time Restricted Feeding on Body Weight and Metabolic Disease Risk Factors in Obese Adults: A Pilot Study. Nutr Healthy Aging (2018) 4:345–53. doi: 10.3233/NHA-170036
67. Gabel K, Marcell J, Cares K, Kalam F, Cienfuegos S, Ezpeleta M, et al. Effect of Time Restricted Feeding on the Gut Microbiome in Adults With Obesity: A Pilot Study. Nutr Health (2020) 26:79–85. doi: 10.1177/0260106020910907
68. Hutchison AT, Regmi P, Manoogian ENC, Fleischer JG, Wittert GA, Panda S, et al. Time-Restricted Feeding Improves Glucose Tolerance in Men at Risk for Type 2 Diabetes: A Randomized Crossover Trial. Obes (Silver Spring) (2019) 27:724–32. doi: 10.1002/oby.22449
69. Jamshed H, Beyl RA, Della Manna DL, Yang ES, Ravussin E, Peterson CM. Early Time-Restricted Feeding Improves 24-Hour Glucose Levels and Affects Markers of the Circadian Clock, Aging, and Autophagy in Humans. Nutrients (2019) 11:1234. doi: 10.3390/nu11061234
70. Ravussin E, Beyl RA, Poggiogalle E, Hsia DS, Peterson CM. Early Time-Restricted Feeding Reduces Appetite and Increases Fat Oxidation But Does Not Affect Energy Expenditure in Humans. Obes (Silver Spring) (2019) 27:1244–54. doi: 10.1002/oby.22518
71. Jones R, Pabla P, Mallinson J, Nixon A, Taylor T, Bennett A, et al. Two Weeks of Early Time-Restricted Feeding (eTRF) Improves Skeletal Muscle Insulin and Anabolic Sensitivity in Healthy Men. Am J Clin Nutr (2020) 112:1015–28. doi: 10.1093/ajcn/nqaa192
72. Karras SN, Koufakis T, Adamidou L, Antonopoulou V, Karalazou P, Thisiadou K, et al. Effects of Orthodox Religious Fasting Versus Combined Energy and Time Restricted Eating on Body Weight, Lipid Concentrations and Glycaemic Profile. Int J Food Sci Nutr (2021) 72:82–92. doi: 10.1080/09637486.2020.1760218
73. Kesztyus D, Cermak P, Gulich M, Kesztyus T. Adherence to Time-Restricted Feeding and Impact on Abdominal Obesity in Primary Care Patients: Results of a Pilot Study in a Pre-Post Design. Nutrients (2019) 11:2854. doi: 10.3390/nu11122854
74. Li C, Xing C, Zhang J, Zhao H, Shi W, He B. Eight-Hour Time-Restricted Feeding Improves Endocrine and Metabolic Profiles in Women With Anovulatory Polycystic Ovary Syndrome. J Trans Med (2021) 19:148. doi: 10.1186/s12967-021-02817-2
75. Lowe DA, Wu N, Rohdin-Bibby L, Moore AH, Kelly N, Liu YE, et al. Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial. JAMA Intern Med (2020) 180:1491–9. doi: 10.1001/jamainternmed.2020.4153
76. Martens CR, Rossman MJ, Mazzo MR, Jankowski LR, Nagy EE, Denman BA, et al. Short-Term Time-Restricted Feeding Is Safe and Feasible in Non-Obese Healthy Midlife and Older Adults. Geroscience (2020) 42:667–86. doi: 10.1007/s11357-020-00156-6
77. McAllister MJ, Pigg BL, Renteria LI, Waldman HS. Time-Restricted Feeding Improves Markers of Cardiometabolic Health in Physically Active College-Age Men: A 4-Week Randomized Pre-Post Pilot Study. Nutr Res (2020) 75:32–43. doi: 10.1016/j.nutres.2019.12.001
78. Moro T, Tinsley G, Bianco A, Marcolin G, Pacelli QF, Battaglia G, et al. Effects of Eight Weeks of Time-Restricted Feeding (16/8) on Basal Metabolism, Maximal Strength, Body Composition, Inflammation, and Cardiovascular Risk Factors in Resistance-Trained Males. J Trans Med (2016) 14:290. doi: 10.1186/s12967-016-1044-0
79. Parr EB, Devlin BL, Lim KHC, Moresi LNZ, Geils C, Brennan L, et al. Time-Restricted Eating as a Nutrition Strategy for Individuals With Type 2 Diabetes: A Feasibility Study. Nutrients (2020) 12:3228. doi: 10.3390/nu12113228
80. Parr EB, Devlin BL, Radford BE, Hawley JA. A Delayed Morning and Earlier Evening Time-Restricted Feeding Protocol for Improving Glycemic Control and Dietary Adherence in Men With Overweight/Obesity: A Randomized Controlled Trial. Nutrients (2020) 12:505. doi: 10.3390/nu12020505
81. Lundell LS, Parr EB, Devlin BL, Ingerslev LR, Altintas A, Sato S, et al. Time-Restricted Feeding Alters Lipid and Amino Acid Metabolite Rhythmicity Without Perturbing Clock Gene Expression. Nat Commun (2020) 11:4643. doi: 10.1038/s41467-020-18412-w
82. Peeke PM, Greenway FL, Billes SK, Zhang D, Fujioka K. Effect of Time Restricted Eating on Body Weight and Fasting Glucose in Participants With Obesity: Results of a Randomized, Controlled, Virtual Clinical Trial. Nutr Diabetes (2021) 11:6. doi: 10.1038/s41387-021-00149-0
83. Phillips NE, Mareschal J, Schwab N, Manoogian ENC, Borloz S, Ostinelli G, et al. The Effects of Time-Restricted Eating Versus Standard Dietary Advice on Weight, Metabolic Health and the Consumption of Processed Food: A Pragmatic Randomised Controlled Trial in Community-Based Adults. Nutrients (2021) 13:1042. doi: 10.3390/nu13031042
84. Sutton EF, Beyl R, Early KS, Cefalu WT, Ravussin E, Peterson CM. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even Without Weight Loss in Men With Prediabetes. Cell Metab (2018) 27:1212–21.e1213. doi: 10.1016/j.cmet.2018.04.010
85. Tinsley GM, Forsse JS, Butler NK, Paoli A, Bane AA, La Bounty PM, et al. Time-Restricted Feeding in Young Men Performing Resistance Training: A Randomized Controlled Trial. Eur J Sport Sci (2017) 17:200–7. doi: 10.1080/17461391.2016.1223173
86. Wilkinson MJ, Manoogian ENC, Zadourian A, Lo H, Fakhouri S, Shoghi A, et al. Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients With Metabolic Syndrome. Cell Metab (2020) 31:92–104 e105. doi: 10.1016/j.cmet.2019.11.004
87. Zeb F, Wu X, Chen L, Fatima S, Haq IU, Chen A, et al. Effect of Time-Restricted Feeding on Metabolic Risk and Circadian Rhythm Associated With Gut Microbiome in Healthy Males. Br J Nutr (2020) 123:1216–26. doi: 10.1017/S0007114519003428
88. Kesztyus D, Fuchs M, Cermak P, Kesztyus T. Associations of Time-Restricted Eating With Health-Related Quality of Life and Sleep in Adults: A Secondary Analysis of Two Pre-Post Pilot Studies. BMC Nutr (2020) 6:76. doi: 10.1186/s40795-020-00402-2
89. Poggiogalle E, Jamshed H, Peterson CM. Circadian Regulation of Glucose, Lipid, and Energy Metabolism in Humans. Metabolism: Clin Exp (2018) 84:11–27. doi: 10.1016/j.metabol.2017.11.017
90. Middleton KR, Anton SD, Perri MG. Long-Term Adherence to Health Behavior Change. Am J Lifestyle Med (2013) 7:395–404. doi: 10.1177/1559827613488867
91. Kanerva N, Kronholm E, Partonen T, Ovaskainen ML, Kaartinen NE, Konttinen H, et al. Tendency Toward Eveningness Is Associated With Unhealthy Dietary Habits. Chronobiol Int (2012) 29:920–7. doi: 10.3109/07420528.2012.699128
92. Munoz JSG, Canavate R, Hernandez CM, Cara-Salmeron V, Morante JJH. The Association Among Chronotype, Timing of Food Intake and Food Preferences Depends on Body Mass Status. Eur J Clin Nutr (2017) 71:736–42. doi: 10.1038/ejcn.2016.182
93. Liu H, Javaheri A, Godar RJ, Murphy J, Ma X, Rohatgi N, et al. Intermittent Fasting Preserves Beta-Cell Mass in Obesity-Induced Diabetes via the Autophagy-Lysosome Pathway. Autophagy (2017) 13:1952–68. doi: 10.1080/15548627.2017.1368596
94. Sato M, Murakami M, Node K, Matsumura R, Akashi M. The Role of the Endocrine System in Feeding-Induced Tissue-Specific Circadian Entrainment. Cell Rep (2014) 8:393–401. doi: 10.1016/j.celrep.2014.06.015
95. Landgraf D, Tsang AH, Leliavski A, Koch CE, Barclay JL, Drucker DJ, et al. Oxyntomodulin Regulates Resetting of the Liver Circadian Clock by Food. Elife (2015) 4:e06253. doi: 10.7554/eLife.06253
96. Chaudhari A, Gupta R, Makwana K, Kondratov R. Circadian Clocks, Diets and Aging. Nutr Healthy Aging (2017) 4:101–12. doi: 10.3233/NHA-160006
Keywords: time restricted eating, circadian clock, chrononutrition, glucose metabolism, lipid metabolism, metabolic diseases
Citation: Schuppelius B, Peters B, Ottawa A and Pivovarova-Ramich O (2021) Time Restricted Eating: A Dietary Strategy to Prevent and Treat Metabolic Disturbances. Front. Endocrinol. 12:683140. doi: 10.3389/fendo.2021.683140
Received: 19 March 2021; Accepted: 23 July 2021;
Published: 12 August 2021.
Edited by:
Julia Szendroedi, Heidelberg University, GermanyReviewed by:
Ibrahim Fadil Benter, Eastern Mediterranean University, TurkeyPatrick Boyd, National Cancer Institute (NCI), United States
Monique Francois, University of Wollongong, Australia
Copyright © 2021 Schuppelius, Peters, Ottawa and Pivovarova-Ramich. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Olga Pivovarova-Ramich, olga.ramich@dife.de